Home LiteratureArticle Details
PMID: 19036793 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Functional and structural characterization of the integrase from the prototype foamy virus.

Nucleic acids research ·Vol. 37 ·No. 1 ·2009-01-00 ·Pages 243-55

Valkov E, Gupta SS, Hare S, Helander A, Roversi P, McClure M, Cherepanov P

Abstract

Establishment of the stable provirus is an essential step in retroviral replication, orchestrated by integrase (IN), a virus-derived enzyme. Until now, available structural information was limited to the INs of human immunodeficiency virus type 1 (HIV-1), avian sarcoma virus (ASV) and their close orthologs from the Lentivirus and Alpharetrovirus genera. Here, we characterized the in vitro activity of the prototype foamy virus (PFV) IN from the Spumavirus genus and determined the three-dimensional structure of its catalytic core domain (CCD). Recombinant PFV IN displayed robust and almost exclusively concerted integration activity in vitro utilizing donor DNA substrates as short as 16 bp, underscoring its significance as a model for detailed structural studies. Comparison of the HIV-1, ASV and PFV CCD structures highlighted both conserved as well as unique structural features such as organization of the active site and the putative host factor binding face. Despite possessing very limited sequence identity to its HIV counterpart, PFV IN was sensitive to HIV IN strand transfer inhibitors, suggesting that this class of inhibitors target the most conserved features of retroviral IN-DNA complexes.

MeSH Terms
Amino Acid Sequence Animals Catalytic Domain Cell Line Crystallography Dogs Enzyme Inhibitors/pharmacology Humans Integrases/chemistry,genetics,metabolism Models, Molecular Molecular Sequence Data Recombinant Proteins/chemistry,metabolism Sequence Analysis, DNA Spumavirus/enzymology Viral Proteins/chemistry,genetics,metabolism
Chemicals
Enzyme Inhibitors Recombinant Proteins Viral Proteins Integrases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Valkov Eugene
Division of Medicine, St. Mary's Campus, Imperial College London, London, UK.
Gupta Saumya Shree
Hare Stephen
Helander Anna
Roversi Pietro
McClure Myra
Cherepanov Peter
References (82)
82 references, click to expand
  1. Scaling and assessment of data quality.
    Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82 PMID: 16369096
  2. Characterization of the functional domains of human foamy virus integrase using chimeric integrases.
    Mol Cells. 2005 Apr 30;19(2):246-55 PMID: 15879710
  3. The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.
    PLoS Pathog. 2008 Mar 28;4(3):e1000046 PMID: 18369482
  4. An active foamy virus integrase is required for virus replication.
    J Gen Virol. 1999 Jun;80 ( Pt 6):1445-1452 PMID: 10374962
  5. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein.
    Nucleic Acids Res. 1993 Mar 25;21(6):1419-25 PMID: 8464733
  6. Crystal structures of RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis.
    Cell. 2005 Jul 1;121(7):1005-16 PMID: 15989951
  7. Retrotransposon Tf1 is targeted to Pol II promoters by transcription activators.
    Mol Cell. 2008 Apr 11;30(1):98-107 PMID: 18406330
  8. Phaser crystallographic software.
    J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674 PMID: 19461840
  9. Automated protein model building combined with iterative structure refinement.
    Nat Struct Biol. 1999 May;6(5):458-63 PMID: 10331874
  10. HIV-1 integrase: structural organization, conformational changes, and catalysis.
    Adv Virus Res. 1999;52:351-69 PMID: 10384242
  11. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.
    Science. 1994 Dec 23;266(5193):1981-6 PMID: 7801124
  12. Genome-wide mapping of foamy virus vector integrations into a human cell line.
    J Gen Virol. 2006 May;87(Pt 5):1339-1347 PMID: 16603537
  13. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
    J Virol. 2006 Feb;80(4):1886-96 PMID: 16439544
  14. The CCP4 suite: programs for protein crystallography.
    Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 PMID: 15299374
  15. Integration site choice of a feline immunodeficiency virus vector.
    J Virol. 2006 Sep;80(17):8820-3 PMID: 16912328
  16. Foamy virus vector integration sites in normal human cells.
    Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1498-503 PMID: 16428288
  17. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.
    Mol Cell Biol. 1992 May;12(5):2331-8 PMID: 1314954
  18. The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding.
    J Virol. 1994 Sep;68(9):5911-7 PMID: 8057470
  19. Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1.
    J Biol Chem. 1995 Feb 17;270(7):2957-66 PMID: 7852375
  20. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases.
    J Mol Biol. 1998 Sep 18;282(2):359-68 PMID: 9735293
  21. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.
    Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9150-4 PMID: 9689049
  22. Stepwise analyses of metal ions in RNase H catalysis from substrate destabilization to product release.
    EMBO J. 2006 May 3;25(9):1924-33 PMID: 16601679
  23. The integration profile of EIAV-based vectors.
    Mol Ther. 2006 Oct;14(4):536-45 PMID: 16950499
  24. A role for LEDGF/p75 in targeting HIV DNA integration.
    Nat Med. 2005 Dec;11(12):1287-9 PMID: 16311605
  25. HIV-1 integration in the human genome favors active genes and local hotspots.
    Cell. 2002 Aug 23;110(4):521-9 PMID: 12202041
  26. Two-metal active site binding of a Tn5 transposase synaptic complex.
    Nat Struct Biol. 2002 Apr;9(4):278-81 PMID: 11896402
  27. Refinement of macromolecular structures by the maximum-likelihood method.
    Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55 PMID: 15299926
  28. Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo.
    J Virol. 2006 Aug;80(15):7316-21 PMID: 16840312
  29. HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.
    AIDS Rev. 2008 Apr-Jun;10(2):67-84 PMID: 18615118
  30. Making and breaking nucleic acids: two-Mg2+-ion catalysis and substrate specificity.
    Mol Cell. 2006 Apr 7;22(1):5-13 PMID: 16600865
  31. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.
    Proc Natl Acad Sci U S A. 1990 Jul;87(13):5119-23 PMID: 2164223
  32. Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0.
    Acta Crystallogr D Biol Crystallogr. 2003 Nov;59(Pt 11):2023-30 PMID: 14573958
  33. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75.
    Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17308-13 PMID: 16260736
  34. Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting.
    PLoS One. 2007 Dec 19;2(12):e1340 PMID: 18092005
  35. A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles.
    Retrovirology. 2005 May 18;2:31 PMID: 15904533
  36. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells.
    J Biol Chem. 2003 Jan 3;278(1):372-81 PMID: 12407101
  37. The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: a three-helix bundle stabilized by zinc.
    Curr Biol. 1997 Oct 1;7(10):739-46 PMID: 9368756
  38. ESPript: analysis of multiple sequence alignments in PostScript.
    Bioinformatics. 1999 Apr;15(4):305-8 PMID: 10320398
  39. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations.
    Structure. 1996 Jan 15;4(1):89-96 PMID: 8805516
  40. HIV-1 integrase crosslinked oligomers are active in vitro.
    Nucleic Acids Res. 2005 Feb 17;33(3):977-86 PMID: 15718297
  41. Solution structure of the DNA binding domain of HIV-1 integrase.
    Biochemistry. 1995 Aug 8;34(31):9826-33 PMID: 7632683
  42. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.
    J Virol. 2005 Jul;79(13):8208-16 PMID: 15956566
  43. Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration.
    J Biol Chem. 2005 Aug 12;280(32):29334-9 PMID: 15958388
  44. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.
    J Med Chem. 2008 Sep 25;51(18):5843-55 PMID: 18763751
  45. Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate.
    J Virol. 2007 Nov;81(22):12189-99 PMID: 17804497
  46. Chromatin tethering of incoming foamy virus by the structural Gag protein.
    Traffic. 2008 Sep;9(10):1717-27 PMID: 18627573
  47. Efficient and rapid affinity purification of proteins using recombinant fusion proteases.
    Biotechnology (N Y). 1994 Jun;12(6):601-5 PMID: 7764949
  48. An essential role for LEDGF/p75 in HIV integration.
    Science. 2006 Oct 20;314(5798):461-4 PMID: 16959972
  49. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication.
    J Biol Chem. 2005 Jul 8;280(27):25517-23 PMID: 15855167
  50. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.
    J Mol Biol. 2000 Feb 18;296(2):521-33 PMID: 10669606
  51. Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant.
    Biochemistry. 1999 Oct 12;38(41):13512-22 PMID: 10521258
  52. Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus.
    J Virol. 1993 Sep;67(9):5426-34 PMID: 7688824
  53. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
    Nucleic Acids Res. 1999 May 15;27(10):2202-10 PMID: 10219094
  54. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.
    J Mol Biol. 2000 Feb 18;296(2):535-48 PMID: 10669607
  55. Retroviral DNA integration--mechanism and consequences.
    Adv Genet. 2005;55:147-81 PMID: 16291214
  56. Human foamy virus reverse transcription that occurs late in the viral replication cycle.
    J Virol. 1997 Oct;71(10):7305-11 PMID: 9311807
  57. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant.
    Gene. 1995 May 26;158(1):9-14 PMID: 7789817
  58. Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini.
    J Virol. 1996 Jun;70(6):3571-80 PMID: 8648691
  59. WebLogo: a sequence logo generator.
    Genome Res. 2004 Jun;14(6):1188-90 PMID: 15173120
  60. Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
    J Med Chem. 2006 Mar 9;49(5):1506-8 PMID: 16509568
  61. Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1.
    J Virol. 2005 Oct;79(19):12199-204 PMID: 16160146
  62. Coot: model-building tools for molecular graphics.
    Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32 PMID: 15572765
  63. Efficient intracellular retrotransposition of an exogenous primate retrovirus genome.
    EMBO J. 2000 Jul 3;19(13):3436-45 PMID: 10880456
  64. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.
    Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8233-8 PMID: 10890912
  65. Foamy virus integration.
    J Virol. 2004 Mar;78(5):2472-7 PMID: 14963145
  66. PHENIX: building new software for automated crystallographic structure determination.
    Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54 PMID: 12393927
  67. Retroviral DNA integration: reaction pathway and critical intermediates.
    EMBO J. 2006 Mar 22;25(6):1295-304 PMID: 16482214
  68. LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro.
    Nucleic Acids Res. 2007;35(1):113-24 PMID: 17158150
  69. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration.
    Genes Dev. 2007 Jul 15;21(14):1767-78 PMID: 17639082
  70. Methods used in the structure determination of bovine mitochondrial F1 ATPase.
    Acta Crystallogr D Biol Crystallogr. 1996 Jan 1;52(Pt 1):30-42 PMID: 15299723
  71. Assembly and catalysis of concerted two-end integration events by Moloney murine leukemia virus integrase.
    J Virol. 2001 Oct;75(20):9561-70 PMID: 11559787
  72. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase.
    Nat Struct Biol. 1997 Jul;4(7):567-77 PMID: 9228950
  73. Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137.
    Antimicrob Agents Chemother. 2008 Jun;52(6):2069-78 PMID: 18378713
  74. Transcription start regions in the human genome are favored targets for MLV integration.
    Science. 2003 Jun 13;300(5626):1749-51 PMID: 12805549
  75. Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease.
    J Virol. 1998 Sep;72(9):7648-52 PMID: 9696869
  76. A short history of SHELX.
    Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22 PMID: 18156677
  77. Insight into the integrase-DNA recognition mechanism. A specific DNA-binding mode revealed by an enzymatically labeled integrase.
    J Biol Chem. 2008 Oct 10;283(41):27838-27849 PMID: 18697740
  78. Genome-wide analysis of retroviral DNA integration.
    Nat Rev Microbiol. 2005 Nov;3(11):848-58 PMID: 16175173
  79. Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p.
    Mol Cell Biol. 2001 Oct;21(19):6606-14 PMID: 11533248
  80. The DNA-binding domain of HIV-1 integrase has an SH3-like fold.
    Nat Struct Biol. 1995 Sep;2(9):807-10 PMID: 7552753
  81. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.
    PLoS Biol. 2004 Aug;2(8):E234 PMID: 15314653
  82. Improved foamy virus vectors with minimal viral sequences.
    Mol Ther. 2002 Sep;6(3):321-8 PMID: 12231167
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
1362-4962
Published
2009-01-00
Epub
2008-00-26
Pages
243-55
Language
English
Region
England
NLM ID
0411011
PMCID
PMC2615609
Subset
IM
Grants
Medical Research Council · G0500367 · United Kingdom
Medical Research Council · G0400389 · United Kingdom
Medical Research Council · G0600009 · United Kingdom
Databases
PDB
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com